PegIFN treatment group:None

To construct an early dynamic change model of HBV-RNA to guide the clinical cure of chronic hepatitis B with a short course of PegIFNa-2b

A prospective study to shorten the course of PegIFNa-2b to achieve clinical cure of CHB according to the baseline and early HBVRNA/HBcrAg levels

Prospective study protocol for predicting clinical cure of CHB with PegIFNa-2b based on baseline and early treatment peripheral blood CD4+PD-1+ and CD8+PD-1+ T cell levels